Imiquimod to treat basal cell and squamous cell carcinomas [2]

American Family Physician

Volumn 72, Issue 1, 2005, Pages 41-

  Keller, Curtis D ^a  

^a 3M COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; DRUG APPROVAL; FOOD AND DRUG ADMINISTRATION; IMMUNOCOMPETENCE; LETTER; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADMINISTRATION, CUTANEOUS; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; DRUG APPROVAL; HUMANS; PATIENT SELECTION; SKIN NEOPLASMS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 21844448859     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Stulberg DL, Crandell B, Fawcett RS. Diagnosis and treatment of basal cell and squamous cell carcinomas. Am Fam Physician 2004;70:1481-8.
2. Aldara [package insert]. St. Paul, Minn.: 3M Pharmaceuticals, 2004.